Compounds > alendronate

alendronate and transforming growth factor beta

alendronate has been researched along with transforming growth factor beta in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Stearns, ME1
Derynck, R; Erlebacher, A; Filvaroff, EH; Ye, JQ1
Bone, A; Destefano, J; Duong, LT; Hayami, T; McLane, J; Pickarski, M; Rodan, GA; Wesolowski, GA1
Chihara, K; Inoue, Y; Kaji, H; Naito, J; Sowa, H; Sugimoto, T1
Carta, L; Cook, JR; Dietz, HC; Lee-Arteaga, S; Nistala, H; Ramirez, F; Rifkin, AN; Rifkin, DB; Siciliano, G; Smaldone, S1
Chan, KM; Li, G; Ni, M; Tang, PF; Wang, Y1
Imaizumi, Y; Kaji, Y; Nakamura, O; Yamagami, Y; Yamamoto, T1
Costa-Casagrande, TA; Cunha, EJ; de Souza, JF; Giovanini, AF; Sant'Ana, RD; Vieira, JS; Zielak, JC1
Akiyama, S; Chazono, M; Inagaki, N; Kakuta, A; Kitasato, S; Komaki, H; Marumo, K; Tanaka, T1

Other Studies

9 other study(ies) available for alendronate and transforming growth factor beta

ArticleYear
Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells.
    Clinical & experimental metastasis, 1998, Volume: 16, Issue:4

    Topics: Alendronate; Antineoplastic Agents; Bone Neoplasms; Collagen; Gelatinases; Humans; Hydroxyproline; Male; Matrix Metalloproteinase 2; Metalloendopeptidases; Prostatic Neoplasms; Transforming Growth Factor beta; Tritium; Tumor Cells, Cultured

1998
Osteoblastic responses to TGF-beta during bone remodeling.
    Molecular biology of the cell, 1998, Volume: 9, Issue:7

    Topics: Alendronate; Animals; Bone Remodeling; Bone Resorption; Cell Count; Cell Differentiation; Femur; Gene Expression Regulation; Kinetics; Mice; Mice, Inbred C57BL; Mice, Transgenic; Minerals; Osteoblasts; Osteoclasts; Osteocytes; Periosteum; Phenotype; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta

1998
The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model.
    Arthritis and rheumatism, 2004, Volume: 50, Issue:4

    Topics: Acid Phosphatase; Alendronate; Animals; Anterior Cruciate Ligament; Bone Remodeling; Calcinosis; Cartilage, Articular; Collagen; Collagen Type I; Collagen Type II; Disease Models, Animal; Disease Progression; Extracellular Matrix Proteins; Glycoproteins; Isoenzymes; Male; Matrilin Proteins; Osteoarthritis, Knee; Osteoclasts; Peptides; Rats; Sclerosis; Severity of Illness Index; Tartrate-Resistant Acid Phosphatase; Transforming Growth Factor beta

2004
Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2008, Volume: 40, Issue:11

    Topics: Alendronate; Animals; Apoptosis; Cell Line; Gene Expression; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Osteoblasts; Quinolines; Rats; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Simvastatin; Smad3 Protein; Transforming Growth Factor beta

2008
Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.
    Human molecular genetics, 2010, Dec-15, Volume: 19, Issue:24

    Topics: Alendronate; Animals; Aorta; Aortic Aneurysm; Bone Diseases, Metabolic; Bone Morphogenetic Proteins; Bone Resorption; Disease Models, Animal; Fibrillin-1; Fibrillins; Losartan; Marfan Syndrome; Mice; Mice, Inbred C57BL; Microfilament Proteins; Mutation; Osteoblasts; Osteoclasts; Osteogenesis; Spine; Tomography, X-Ray Computed; Transforming Growth Factor beta

2010
rhBMP-2 not alendronate combined with HA-TCP biomaterial and distraction osteogenesis enhance bone formation.
    Archives of orthopaedic and trauma surgery, 2011, Volume: 131, Issue:11

    Topics: Alendronate; Animals; Biocompatible Materials; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Hydroxyapatites; Male; Osteogenesis; Osteogenesis, Distraction; Rabbits; Recombinant Proteins; Transforming Growth Factor beta

2011
Prefabrication of vascularized bone allograft in a recipient rat using a flow-through vascular pedicle, bone morphogenetic protein, and bisphosphonate.
    Journal of reconstructive microsurgery, 2013, Volume: 29, Issue:4

    Topics: Alendronate; Animals; Arteries; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Resorption; Bone Transplantation; Bony Callus; Diphosphonates; Female; Femur; Fluoresceins; Fluorescent Dyes; Male; Microradiography; Microsurgery; Osteogenesis; Rats; Rats, Sprague-Dawley; Rats, Wistar; Recombinant Proteins; Saphenous Vein; Thigh; Tissue Preservation; Transforming Growth Factor beta; Transplantation, Homologous

2013
Alendronate induces postnatal maxillary bone growth by stimulating intramembranous ossification and preventing premature cartilage mineralization in the midpalatal suture of newborn rats.
    International journal of oral and maxillofacial surgery, 2019, Volume: 48, Issue:11

    Topics: Alendronate; Animals; Animals, Newborn; Bone Morphogenetic Protein 2; Cartilage; Maxilla; Osteogenesis; Rats; Sutures; Transforming Growth Factor beta

2019
Local application of alendronate controls bone formation and β-tricalcium phosphate resorption induced by recombinant human bone morphogenetic protein-2.
    Journal of biomedical materials research. Part A, 2020, Volume: 108, Issue:3

    Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Resorption; Calcium Phosphates; Female; Humans; Osteogenesis; Rabbits; Recombinant Proteins; Transforming Growth Factor beta

2020